CASP3 and Hyperglycemia: Surprisingly, CoPP treatment significantly attenuated the expressions of activated caspase-3 in ARPE-19 cells under hyperglycemia but displayed high activated caspase-3 expressions in the cells under normoglycemia (Figure 3J).